Endometrial Neoplasm — Trials

Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,340 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–14 of 14 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04634877	Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)	active not recruiting	Phase 3	990	Merck Sharp & Dohme LLCINDUSTRY	28	Sep 18, 2026	clinicaltrials
NCT06132958	Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)(TroFuse-005)	active not recruiting	Phase 3	710	Merck Sharp & Dohme LLC